Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Zynex unveils two new therapy products for rehabilitation

EditorRachael Rajan
Published 20/02/2024, 14:28
© Reuters.
ZYXI
-

ENGLEWOOD, Colo. - Zynex , Inc. (NASDAQ: NASDAQ:ZYXI), a medical technology firm known for non-invasive medical devices for pain management and rehabilitation, has launched two new products aimed at enhancing patient care. The company introduced the Zynex Pro Hybrid LSO, a spinal orthosis designed for comfort and adaptability, and the Zynex DynaComp Cold Compression, a device combining cold therapy with compression to aid recovery.

The Zynex Pro Hybrid LSO is presented as a 3-in-1 spinal brace with a modular design to meet various patient requirements, from rehabilitation to recovery. Meanwhile, the Zynex DynaComp Cold Compression offers portable cold therapy and compression, targeting muscle soreness, swelling, and inflammation.

Thomas Sandgaard, Founder and CEO of Zynex, expressed enthusiasm about the new offerings, stating they allow the company's sales force to compete effectively in the cold compression and bracing markets. He also mentioned the products align with Zynex's strategy to diversify revenue and enhance shareholder value.

Zynex, established in 1996, has a portfolio of medical devices for pain management and rehabilitation. Additionally, they provide non-invasive monitoring systems for hospitals. These new products are part of the company's expansion into different segments of the medical device market.

The information in this article is based on a press release statement from Zynex, Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.